248 related articles for article (PubMed ID: 16149876)
1. Epitomics: serum screening for the early detection of cancer on microarrays using complex panels of tumor antigens.
Draghici S; Chatterjee M; Tainsky MA
Expert Rev Mol Diagn; 2005 Sep; 5(5):735-43. PubMed ID: 16149876
[TBL] [Abstract][Full Text] [Related]
2. Discovery of antibody biomarkers using protein microarrays of tumor antigens cloned in high throughput.
Chatterjee M; Wojciechowski J; Tainsky MA
Methods Mol Biol; 2009; 520():21-38. PubMed ID: 19381945
[TBL] [Abstract][Full Text] [Related]
3. Immunotheranostics: breaking tolerance in immunotherapy using tumor autoantigens identified on protein microarrays.
Chatterjee M; Draghici S; Tainsky MA
Curr Opin Drug Discov Devel; 2006 May; 9(3):380-5. PubMed ID: 16729735
[TBL] [Abstract][Full Text] [Related]
4. Protein arrays for biomarker discovery.
Reid JD; Parker CE; Borchers CH
Curr Opin Mol Ther; 2007 Jun; 9(3):216-21. PubMed ID: 17608019
[TBL] [Abstract][Full Text] [Related]
5. Discovery and application of protein biomarkers for ovarian cancer.
Gagnon A; Ye B
Curr Opin Obstet Gynecol; 2008 Feb; 20(1):9-13. PubMed ID: 18196999
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies in cancer: prognostic biomarkers and immune activation.
Järås K; Anderson K
Expert Rev Proteomics; 2011 Oct; 8(5):577-89. PubMed ID: 21999829
[TBL] [Abstract][Full Text] [Related]
7. Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling.
Linkov F; Lisovich A; Yurkovetsky Z; Marrangoni A; Velikokhatnaya L; Nolen B; Winans M; Bigbee W; Siegfried J; Lokshin A; Ferris RL
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):102-7. PubMed ID: 17220337
[TBL] [Abstract][Full Text] [Related]
8. Discovery and validation of ovarian cancer biomarkers utilizing high density antibody microarrays.
Ramirez AB; Lampe PD
Cancer Biomark; 2010-2011; 8(4-5):293-307. PubMed ID: 22045360
[TBL] [Abstract][Full Text] [Related]
9. Autoantibody to tumor antigen, alpha 2-HS glycoprotein: a novel biomarker of breast cancer screening and diagnosis.
Yi JK; Chang JW; Han W; Lee JW; Ko E; Kim DH; Bae JY; Yu J; Lee C; Yu MH; Noh DY
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1357-64. PubMed ID: 19423516
[TBL] [Abstract][Full Text] [Related]
10. A protein chip system for parallel analysis of multi-tumor markers and its application in cancer detection.
Sun Z; Fu X; Zhang L; Yang X; Liu F; Hu G
Anticancer Res; 2004; 24(2C):1159-65. PubMed ID: 15154641
[TBL] [Abstract][Full Text] [Related]
11. Antibody microarray profiling of human prostate cancer sera: antibody screening and identification of potential biomarkers.
Miller JC; Zhou H; Kwekel J; Cavallo R; Burke J; Butler EB; Teh BS; Haab BB
Proteomics; 2003 Jan; 3(1):56-63. PubMed ID: 12548634
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens.
Zhang JY; Casiano CA; Peng XX; Koziol JA; Chan EK; Tan EM
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):136-43. PubMed ID: 12582023
[TBL] [Abstract][Full Text] [Related]
13. Serum markers for prostate cancer: a rational approach to the literature.
Steuber T; O'Brien MF; Lilja H
Eur Urol; 2008 Jul; 54(1):31-40. PubMed ID: 18243505
[TBL] [Abstract][Full Text] [Related]
14. Multianalyte profiling of serum antigens and autoimmune and infectious disease molecules to identify biomarkers dysregulated in epithelial ovarian cancer.
Bertenshaw GP; Yip P; Seshaiah P; Zhao J; Chen TH; Wiggins WS; Mapes JP; Mansfield BC
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2872-81. PubMed ID: 18843033
[TBL] [Abstract][Full Text] [Related]
15. Improvement of protein immobilization for the elaboration of tumor-associated antigen microarrays: application to the sensitive and specific detection of tumor markers from breast cancer sera.
Yang Z; Chevolot Y; Géhin T; Solassol J; Mange A; Souteyrand E; Laurenceau E
Biosens Bioelectron; 2013 Feb; 40(1):385-92. PubMed ID: 23017679
[TBL] [Abstract][Full Text] [Related]
16. Development of a "reverse capture" autoantibody microarray for studies of antigen-autoantibody profiling.
Qin S; Qiu W; Ehrlich JR; Ferdinand AS; Richie JP; O'leary MP; Lee ML; Liu BC
Proteomics; 2006 May; 6(10):3199-209. PubMed ID: 16596707
[TBL] [Abstract][Full Text] [Related]
17. Use of a combination of approaches to identify and validate relevant tumor-associated antigens and their corresponding autoantibodies in ovarian cancer patients.
Gagnon A; Kim JH; Schorge JO; Ye B; Liu B; Hasselblatt K; Welch WR; Bandera CA; Mok SC
Clin Cancer Res; 2008 Feb; 14(3):764-71. PubMed ID: 18245537
[TBL] [Abstract][Full Text] [Related]
18. Progress in biomarker discovery for diagnostic testing in epithelial ovarian cancer.
Gogoi R; Srinivasan S; Fishman DA
Expert Rev Mol Diagn; 2006 Jul; 6(4):627-37. PubMed ID: 16824035
[TBL] [Abstract][Full Text] [Related]
19. Biomarker discovery using protein microarray technology platforms: antibody-antigen complex profiling.
Mattoon D; Michaud G; Merkel J; Schweitzer B
Expert Rev Proteomics; 2005 Dec; 2(6):879-89. PubMed ID: 16307517
[TBL] [Abstract][Full Text] [Related]
20. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
